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Oxidative stress is a pathological feature of many neurological
disorders; therefore, utilizing proteins that are protective
against such cellular insults is a potentially valuable therapeutic
approach. Oxidation resistance 1 (OXR1) has been shown pre-
viously to be critical for oxidative stress resistance in neuronal
cells; deletion of this gene causes neurodegeneration in mice, yet
conversely, overexpression of OXR1 is protective in cellular and
mouse models of amyotrophic lateral sclerosis. However, the
molecular mechanisms involved are unclear. OXR1 contains the
Tre2/Bub2/Cdc16 (TBC), lysin motif (LysM), domain catalytic
(TLDc) domain, a motif present in a family of proteins including
TBC1 domain family member 24 (TBC1D24), a protein mutated
in a range of disorders characterized by seizures, hearing loss,
and neurodegeneration. The TLDc domain is highly conserved
across species, although the structure-function relationship is
unknown. To understand the role of this domain in the stress
response, we carried out systematic analysis of all mammalian
TLDc domain-containing proteins, investigating their expres-
sion and neuroprotective properties in parallel. In addition, we
performed a detailed structural and functional study of this
domain in which we identified key residues required for its
activity. Finally, we present a new mouse insertional mutant of
Oxr1, confirming that specific disruption of the TLDc domain in
vivo is sufficient to cause neurodegeneration. Our data demon-
strate that the integrity of the TLDc domain is essential for con-
ferring neuroprotection, an important step in understanding
the functional significance of all TLDc domain-containing pro-
teins in the cellular stress response and disease.
Oxidative stress arises from the accumulation of reactive
oxygen species (ROS)2 generated by oxygen metabolism that
can in turn lead to lipid, protein and DNA damage, and ulti-
mately cell death (1–3). Significantly, oxidative stress is impli-
cated in many progressive neurodegenerative disorders,
including Alzheimer disease, Parkinson disease, and amyo-
trophic lateral sclerosis (ALS), yet the exact role of this process
in neuronal cell death is still unclear (4, 5). Given the impor-
tance of oxidative stress in many disease states, it has been sug-
gested that proteins that counteract or reduce the levels of ROS
in cells could be employed for therapeutic benefit (2, 6).
The oxidation resistance 1 (OXR1) gene was originally iden-
tified in a screen conducted in Escherichia coli for genes that
were able to protect cells against oxidative damage (7). We and
others demonstrated subsequently that modulating the levels
of OXR1 can influence the cellular response to oxidative stress
(8 –12) and that loss or disruption of OXR1 or its orthologues in
vivo results in early lethality and selective neurodegeneration
(8, 11, 13). Furthermore, we went on to show that overexpres-
sion of Oxr1 could delay pathogenesis in a mouse model of ALS
(14) as well as restore the cellular defects associated with famil-
ial ALS mutations (15). Despite these findings, the function of
OXR1 remains unknown. It is noteworthy, however, that OXR1
contains a conserved protein motif of 200 amino acids named
the TLDc domain (16 –18). Moreover, OXR1 is expressed as
several isoforms that all contain this C-terminal region, and it
has been shown that even the shortest of these isoforms func-
tionally compensates for the full-length protein in vitro (8).
This suggests that it is the TLDc domain that plays a key role in
oxidative stress resistance.
In mammals the TLDc domain is also found in a family of
proteins including nuclear receptor coactivator 7 (NCOA7),
TBC1D24, KIAA1609 (also referred to as TLDC1), and
C20ORF118 (or TLDC2) (19). In addition to studies on OXR1,
TBC1D24 is associated with a range of severe human neurolog-
ical disorders. An increasing series of compound heterozygous
and homozygous TBC1D24 coding and frameshift mutations
has been identified, including mutations in the TLDc domain
itself, which cause diverse forms of epileptic syndromes includ-
ing familial myoclonic epilepsy (20, 21, 25), familial malignant
migrating partial seizures of infancy (22), early infantile epilep-
tic encephalopathy (27), deafness, onychodystrophy, osteodys-
trophy, and mental retardation syndrome (DOORS) (23), neu-
rodegeneration (25), non-syndromic hearing impairment (26,
27), focal epilepsy associated with intellectual disabilities (24,
25), and more recently, multifocal myoclonus involving cere-
bellar dysfunction (28). Initial functional studies of TBC1D24
have focused on the TBC domain, suggesting that mutant forms
of the protein influence cortical maturation and migration via
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control of GTP-binding protein ADP-ribosylation factor 6
(ARF6) activation (21, 29) as well as vesicle recycling in neurons
(30, 31). Taken together, these data suggest that OXR1 and
TBC1D24 are important for normal brain function. NCOA7 is
also expressed in the brain (32), although nothing is known
regarding its transcriptional role in the nervous system. To
assist these studies, the three-dimensional structure of the
TLDc domain has been solved (17). Nevertheless, due in part to
the lack of structural similarity to known protein folds, it
remains unclear whether other TLDc proteins possess similar
functional properties and how the TLDc domain contributes to
essential cellular processes; indeed, there is no evidence that the
TLDc domain imparts catalytic properties as originally pre-
dicted (18).
To, therefore, understand the functional significance of this
domain, we carried out a structural-functional study of all
mammalian TLDc proteins, demonstrating that they share a
common protective role in neurons and identifying critical res-
idues in the domain. Our data provide valuable new insight into
the function of TLDc domain-containing proteins in the neu-
ronal stress response.
Experimental Procedures
In Situ Hybridization—Regions representing all isoforms of
Oxr1 (2723–3139 bp of NCBI accession number NM_130885),
Ncoa7 (2650 –3284 bp of NM_172495), Tbc1d24 (2705–3558
bp of NM_001163847), Kiaa1609 (1337–1959 bp of
NM_028883), and C20Orf118 (231– 620 bp of NM_001177439)
were amplified by RT-PCR or PCR and cloned into pCR4-
TOPO (Invitrogen). Riboprobe synthesis and slide hybridiza-
tion was carried out as previously described (33). All slides
shown were developed for 16 h.
Quantitative Real-time PCR (qRT-PCR)—Total RNA was
extracted from Neuro 2a (N2a) cells using an RNeasy mini kit
(Qiagen) and reversed-transcribed (ThermoScientific). Subse-
quent qRT-PCR was performed in an ABI PRISM 7000
sequence detection system (Applied Biosystems) using SYBR
Green PCR master mix (Applied Biosystems) and primers
shown in Table 1. The housekeeping gene Gapdh was used as
an internal normalizing control, and the Ct method was
used to calculate the level of mRNA -fold changes, or the mean
Ct value of each TLDc gene was compared with the mean Ct
value for C20Orf118.
In Silico Analysis—Alignments were produced with T-Coffee
(34) using default parameters and refined manually. Protein
alignments are presented using Belvu (35) with a coloring
scheme indicating the average BLOSUM62 scores (which are
correlated with amino acid conservation) of each alignment
column: red (3.5), purple (between 3.5 and 2), and light yellow
(between 2 and 0.5). Sequences were named with their Uniprot
identifiers. The corresponding secondary structures were
acquired from the zebrafish OXR2-TLDc domain structure
(PDB ID 4ACJ) (17). The NCOA7-B structural model was cre-
ated using Modeler (36) based on the zebrafish OXR2-TLDc
domain structure (PDB ID 4ACJ) (17). The NCOA7-B-TLDc
domain model is presented using PyMOL. The amino acid evo-
lutionary conservation was based on alignment BLOSUM62
scores.
Constructs and Mutagenesis—Full-length cDNAs represent-
ing mouse Ncoa7, Tbc1d24, Kiaa1609, and C20Orf118 (acces-
sion numbers as above) and short isoform Ncoa7-B were cloned
into a pcDNA3 vector with an HA tag in-frame at the C-termi-
nus. Oxr1-FL and Oxr1-C have been described previously
(8). For Ncoa7, Tbc1d24, and Kiaa1609 knockdown experi-
ments, shRNA constructs were purchased from Sigma
(NM_172495.5–2897s21c1, NM_173186.2–1208s1c1, and
NM_028883.2–256s1c1, respectively). Site-directed muta-
genesis was used to introduce the various mutations into the
pcDNA3 constructs above as per the manufacturer’s protocol
(Agilent Technologies) and confirmed by sequencing.
Cell Culture, Transfection, and Treatment—Neuronal N2a
cells were cultured in DMEM supplemented with glutamax
(Gibco), 1% penicillin-streptomycin (Gibco), and 10% fetal calf
serum (Gibco). Cells were transfected with either FuGENE 6
(Promega) for 48 h (for shRNA experiments and overexpres-
sion for lipid peroxidation and S-nitrosylation assays) or Mag-
netofection (OZBiosciences) for 24 h (for all other overexpres-
sion experiments) as per the manufacturers’ protocol. Cells
were treated with arsenite (50 M for 5 h to quantify ROS, 50 M
for 4 h lipid peroxidation and S-nitrosylated assays, or 150 M
for 4 h to quantify cell death) in water or with water-only as a
control. To visualize pyknotic nuclei, cells were fixed with 4%
paraformaldehyde for 10 min at room temperature, washed
with PBS twice, blocked with blocking buffer (5% goat serum,
0.5% Triton X-100) for 1 h at room temperature, and mounted
in DAPI medium (Vectorlabs). Cells were visualized using a
fluorescent microscope (Leica), and those with typical con-
densed and fragmented nuclei were counted as pyknotic cells.
Anti-HA immunostaining was carried out as previously
described (15).
Purified Cortical Cell Cultures—Cortical cells from wild-type
P1 pups were prepared and cultured as previously described
(37). Briefly, cortices were dissected in cold Hanks’ balanced
salt solution (Gibco), and meninges and hippocampi were
removed and trypsinized for 15 min at 37 °C. Trypsin was inac-
tivated using trypsin inhibitor (Life Technologies) for 5 min,
and cortices were triturated and purified on an OptiPrep gradi-
ent following Brewer and Torricelli (37). Cells were plated in
culture medium (Neurobasal phenol-free, 5% FCS, 2% B27, 0.5
TABLE 1
List of primers used for qRT-PCR






Oxr1 C F CCATAAATACACTCTGGTAGTGTCG
Oxr1 C R TTTGGTCGGAAAGATTCAGG
Ncoa7 FL F TGTCGCTACTTCACTGATGG
Ncoa7 FL R GCGTCTTTGATCTTCATGTG
Ncoa7 B F GCCCCTGGACATTCAGATT
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mM L-glutamine, Gibco) and cultured for 5 days before treating
with vehicle or arsenite (0.5 M for 2 h).
Dihydroethidium Assay—Cells were cultured in 96-well
plates as described above. Cells were treated for 5 h with arsen-
ite (50 M) or vehicle supplemented with dihydroethidium
(Sigma) diluted in culture medium (15 M). After experimental
treatment, cells were washed twice in PBS, wells were filled with
100 l PBS, and the fluorescence was immediately measured on
a FluostarOmega (BMG Labtech) plate reader at an excitation
wavelength of 430 nm and an emission wavelength of 590 nm.
Lipid Peroxidation Assay—N2a cells were transfected for
48 h and treated with 50 M arsenite for 4 h before the levels of
lipid peroxidation were quantified using a lipid peroxidation
assay as per the manufacturer’s protocol (Abcam). Briefly, one
confluent 63-cm2 dish was used per condition, and cells were
washed with cold PBS, homogenized by sonication in the lysis
buffer provided, and clarified by centrifugation. Three volumes
of thiobarbituric acid were added to the samples and incubated
for 1 h at 95 °C. Samples containing a known concentration of
malondialdehyde were processed in parallel and used to gener-
ate a standard curve. Samples were transferred to a transparent
96-well plate, and absorbance was read in duplicate at 532 nm
on a FluostarOmega (BMG Labtech) plate reader.
S-Nitrosylated Protein Assay—N2a cells were transfected for
48 h on coverslips and treated with 50 M arsenite for 4 h, and
the levels of S-nitrosylated proteins were assessed by using a
S-NO protein detection kit (Cayman). Cells were fixed with 4%
paraformaldehyde for 20 min at room temperature and subse-
quently washed and blocked using buffers provided following
the manufacturer’s protocol. Cells were incubated with reduc-
ing and labeling reagents for 1 h at room temperature followed
by incubation for an additional hour with fluorescein detection
reagent. Cells were observed by fluorescence microscopy
(Leica). All images were captured using Axiovision software.
The signal intensity of each cell was measured using ImageJ
software and expressed as the mean gray value divided by the
surface of the cell. Approximately 40 cells were assessed per
condition.
Tissue Staining—Terminal deoxynucleotidyltransferase
dUTP nick end labeling (TUNEL) staining was carried out on
fresh frozen brain sections as recommended by the manufac-
turer (In situ cell death kit, Roche Applied Science). For quan-
tification, four 12 M sections at 60 M intervals across the
midline of the cerebellum were counted for TUNEL-positive
cells per replicate. -Galactosidase staining was also carried out
on fresh frozen brain sections as previously described (38).
Western Blotting—Protein extracts were prepared from cells
using standard radioimmunoprecipitation assay buffer, and
protein levels were quantified using BCA assays (Millipore).
Proteins were run on pre-cast NuPAGE Bis-Tris gels (Life
Technologies) and transferred as per the manufacturer’s proto-
col. Primary antibodies used were as follows: Ncoa7 (Abcam
ab103993), Oxr1 (antiserum as previously described (8)),
Tbc1d24 p14 (Santa Cruz), Kiaa1609 (Biorbyt), and -actin
(Abcam).
Animals—All experiments were conducted in adherence
to the guidelines set forth by the UK Home Office regula-
tions and with the approval of the University of Oxford Eth-
ical Review Panel. The Oxr1 “knock-out first” allele
(Oxr1tm1a(EUCOMM)Wtsi) was generated as part of the Interna-
tional Knock-out Mouse Consortium (IKMC) program (IKMC
project 84243). Briefly, a L1L2_Bact_P cassette was inserted
after exon 12 of Oxr1, composed of a splice acceptor site and
lacZ followed by neomycin under control of the human -actin
promoter (see Fig. 6 and Ref. 39). Thus the lacZ reporter is
designed to be under the control of the native promoter of
Oxr1-FL and Oxr1-C. Intercrossing of mice heterozygous for
the tm1a allele was used to generate homozygous animals, thus
maintaining the line on a C57BL/6N background.
Statistical Analysis—Prism GraphPad software was used for
one-way ANOVA with Dunnett’s multiple comparison test or t
tests. Quantified data are presented S.E.
Results
TLDc Domain-containing Genes Show Distinct Tissue Distri-
bution Patterns—To compare systematically the expression
pattern of all the TLDc domain-encoding genes in parallel, we
quantified their mRNA levels in a range of organs from wild-
type mice. For Oxr1 and Ncoa7 we assayed the full-length tran-
scripts (Oxr1-FL and Ncoa7-FL) in addition to the shortest
known isoforms that almost exclusively contain the TLDc
domain, Oxr1-C (9, 15) and Ncoa7-B (40) (equivalent to human
NCOA7-AS) (41) (Fig. 1A). We showed that Oxr1-FL, Oxr1-C,
Ncoa7-FL, and Tbc1d24 are the most highly expressed TLDc
genes in the central nervous system (Fig. 1B). In addition, both
Ncoa7 isoforms tested are more highly expressed in the kidney,
liver, lung, and spleen than other TLDc genes, suggesting that
Ncoa7 has a specific function in these peripheral organs (Fig.
1B). Interestingly, the relative expression of Ncoa7-FL and
Oxr1-FL is significantly higher than their corresponding short
isoforms in several tissues, supporting the notion that these
specific isoforms are differentially or independently regulated
(Fig. 1B). We next used in situ hybridization to determine the
anatomical localization of the TLDc domain-encoding genes
during development at embryonic day (E) 14.5 using riboprobes
spanning exons common to all known isoforms. These data
show that Oxr1 and Ncoa7 are expressed throughout the devel-
oping embryo, whereas Tbc1d24 expression is more localized
to the brain, spinal cord, and liver (Fig. 1C). Kiaa1609 and
C20orf118 were, however, virtually undetectable at this devel-
opmental time point (Fig. 1C). Lastly, we investigated the local-
ization of the TLDc-encoding genes in the adult brain, and we
showed that Ncoa7, Oxr1, and Tbc1d24 are expressed in all
major structural regions, particularly in the cortex, hippocam-
pus, and cerebellum, with Ncoa7 expression enriched in Pur-
kinje cells as opposed to the cerebellar granule cell layer for
Oxr1 and Tbc1d24 (Fig. 1C). In agreement with our qRT-PCR
data, Kiaa1609 is expressed at a generally low level, although
expression in the hippocampus is apparent (Fig. 1C).
All TLDc Proteins Are Able to Confer Protection against Oxi-
dative Stress—Because Oxr1 is known to play a role in the oxi-
dative stress response, we sought to determine whether other
TLDc proteins, despite their contrasting sizes and additional
domains, share any of these important functional characteris-
tics. To assess this we first quantified the cell viability of neu-
rons transfected with either full-length TLDc constructs or
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Ncoa7-B or Oxr1-C under arsenite treatment, a well-character-
ized oxidative stress inducer. Interestingly, we found that
expression of every TLDc domain-containing protein signifi-
cantly reduced the proportion of dying neurons as compared
with cells transfected with an empty control vector (Fig. 2A). All
TLDc proteins reduced the proportion of cell death by at least
half, and Ncoa7-B appeared to be the most potent neuroprotec-
tive protein in this assay, reducing cell death by up to 85% as
compared with control cells (Fig. 2A). There was no difference
in the levels of cell death between untreated cells expressing the
TLDc constructs or the control vector, confirming that overex-
pressing these proteins was not toxic to the cells (data not
shown).
We showed in a previous study that knockdown of Oxr1 led
to increased neuronal sensitivity to oxidative stress in vitro (8);
thus we investigated whether similar effects would be observed
for other TLDc proteins. We were able to knock down Ncoa7,
Tbc1d24, and Kiaa1609 in N2a cells using shRNAs by 64, 54,
and 64% at the RNA level, respectively (Fig. 2B), and 50% at
the protein level (Fig. 2C). Treatment of these cells with arsenite
led to a small but non-significant increase in cell death com-
pared with those transfected with a control scramble shRNA
vector (Fig. 2D). To compare these findings with Oxr1, we
knocked down this gene by as much as 82% of the normal RNA
level using increasing concentrations of transfected shRNA
(Fig. 2E) and showed a corresponding 80% decrease at the pro-
tein level (Fig. 2F). Interestingly, only at the 82% mRNA knock-
down level was there a significant increase in cell death under
the same oxidative stress conditions (Fig. 2G). These data sug-
gest that reducing the expression levels of TLDc genes to
around two-thirds that of their normal level is not sufficient to
elicit a change in oxidative stress sensitivity.
It has also been suggested that the levels of OXR1 can be
induced as part of the oxidative stress response (9); hence, we
next determined whether other TLDc proteins share the same
properties by quantifying their mRNA levels in purified pri-
mary cortical neurons treated with arsenite. Ncoa7-FL and
Oxr1-C were induced significantly by this treatment, whereas
FIGURE 1. The TLDc members have specific expression patterns in various organs in embryonic and adult wild-type mice. A, a schematic of the TLDc
family members indicating their respective unique and shared domains. LysM, lysin motif; GRAM, GRAM domain; ERbd, estrogen receptor binding domain.
Numbers indicate amino acid positions in the corresponding mouse protein. B, qRT-PCR of TLDc domain-encoding genes from the tissues indicated from male
mice. Data are shown relative to expression of C20Orf118 and are represented as the mean  S.E. *, p  0.05; **, p  0.01; ***, p  0.001; t test. C, in situ
hybridization of TLDc domain-containing genes in the embryo (E14.5, left panel), adult brain (middle panel), or adult cerebellum (right panel) from wild-type
male mice. Riboprobes were designed to span all isoforms of each gene. Scale bars: 1 mm (left and middle panel) and 200 M (right panel).
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the levels of the other TLDc genes remained unchanged (Fig.
2H), suggesting that Ncoa7-FL and Oxr1-C are more likely to
participate in the oxidative stress response under arsenite
treatment.
To provide some mechanistic insight into how overexpres-
sion of TLDc proteins could be neuroprotective, we tested
whether it might occur by reducing the oxidative stress level in
cells. Thus we quantified the level of ROS using the fluorescent
dye dihydroethidium in N2a cells transfected with each of the
wild-type TLDc constructs and then treated with arsenite. We
showed that overexpression of Oxr1-FL, Oxr1-C, and Ncoa7-B
significantly decreased the level of cellular oxidative stress,
whereas the other TLDc proteins caused only a small reduction
without reaching significance (Fig. 2I). Taken together, our data
show that all of the TLDc domain-containing proteins can be
neuroprotective, yet Ncoa7-FL, Tbc1d24, Kiaa1609, and
C20Orf118 were unable to reduce the level of oxidative stress in
treated cells. Therefore, our results indicate that the TLDc
domain can elicit some of its functional effects alone, yet the
context of this domain among the additional protein motifs in
each protein may influence these properties.
The TLDc Domain Contains Highly Conserved Residues
Required for Its Neuroprotective Function—Next, we investi-
gated how the neuroprotective function of the TLDc proteins
may be driven by the conserved TLDc domain. Initially, we
performed a protein alignment of this region using sequences
from humans to yeast (Schizosaccharomyces pombe) to assist in
the identification of the most conserved amino acids and struc-
tural features (Fig. 3). These analyses predicted 4 -helices and
10 -strands and identified 10 residue positions within the
domain that were highly conserved in all species analyzed (Fig.
3). We hypothesized that these particular residues would be
FIGURE 2. The TLDc members are neuroprotective against oxidative stress. A, D, and G, N2a cells were transfected with the constructs indicated and treated
with 150 M arsenite for 4 h. Cell death was quantified by counting the number of cells with pyknotic nuclei. A, overexpression of all TLDc proteins significantly
reduces the proportion of cell death compared with transfection of a control empty vector. B, levels of Ncoa7, Tbc1d24, and Kiaa1609 were significantly knocked
down in shRNA-transfected N2a cells compared with shRNA scramble-transfected cells. C, representative Western blots and quantification showed that the
same shRNA constructs significantly reduced protein expression levels. D, no significant difference in cell death occurred in Ncoa7, Tbc1d24, and Kiaa1609
knockdown cells compared with the control shRNA. Increasing concentrations of an shRNA against Oxr1 leads to increasing knockdown at the RNA and protein
level (E) as shown by a representative Western blots and quantification (F). G, knockdown of Oxr1 by 82% led to a significant increase in cell death under
oxidative stress. H, the mRNA levels of TLDc members under oxidative stress were assessed by qRT-PCR on RNA extracted from purified primary cortical neurons
cultured for 5 days and treated with 0.5 M arsenite for 2 h. The Ncoa7-FL and Oxr1-C transcripts are significantly induced by arsenite treatment compared with
vehicle-treated cells. I, N2a cells overexpressing each one of the wild-type TLDc proteins were treated with 50 M arsenite for 5 h. The level of cellular oxidative
stress was quantified using the fluorescent dihydroethidium and compared with the level of fluorescence in cells transfected with empty control vector. Data
are represented as the mean  S.E. *, p  0.05; **, p  0.01; ***, p  0.001, one-way ANOVA with Dunnett’s multiple comparison test or t test).
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essential for the function of this domain and used an alanine-
scanning approach, mutating six of the most conserved amino
acids of Ncoa7-B, to investigate the functional consequences.
We chose to focus on Ncoa7-B as it is almost entirely composed
of the TLDc domain (40), it is expressed from an independent
promoter in mammalian cells (41), and it represented the most
potent neuroprotective TLDc domain-containing protein we
tested in neurons (Fig. 2A).
We first confirmed that all Ncoa7-B mutants could be
expressed efficiently in N2a cells and that the mutations did not
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affect the cytoplasmic localization of Ncoa7-B (Fig. 4A). Next,
to assess how these mutations influence the neuroprotective
function of the TLDc domain, we quantified cell survival under
oxidative stress. Expression of three Ncoa7-B mutants led to a
significant reduction in cell death compared with the control
vector, suggesting that these mutations were not highly detri-
mental to Ncoa7-B function (Fig. 4B). Interestingly, however,
three of the mutants failed to cause the same reduction in cell
death and, therefore, appeared to be the most functionally dis-
rupted: G93A, G174A, and E216A (numbering based on
Ncoa7-B protein sequence NP_001104737) (Fig. 3).
We then predicted the consequences of mutating these four
specific amino acids on the structure of the TLDc domain of
Ncoa7-B using the published zebrafish three-dimensional
structure (17) (Fig. 3). We predicted that Gly-93 is likely to be
required to maintain the position of -helices 3 and 4 (42) (Fig.
4C). This suggests that the structural integrity of the superficial
helix may be important for function of the TLDc domain. Glu-
216 is one of the most evolutionarily conserved positions in the
TLDc domain, and structural predictions suggest that a hydro-
gen bond between the carboxylate group of Glu-216 and the
amide group of Ser-60 maintains the position of the N-terminal
FIGURE 3. The TLDc domain is highly conserved across species. Alignment of 48 TLDc domain-containing proteins. Colors corresponds to the amino acid
conservation of each alignment column: red (highly conserved), purple (mildly conserved), and light yellow (poorly conserved based on BLOSUM62 scores).
Residues mutated in this study are labeled according to reference protein sequences for human NCOA7-B (red), human NCOA7-(FL) (magenta), and the
zebrafish OXR2-TLDc sequence (PDB ID 4ACJ, purple) (17). The limits of the protein sequences included in the alignment are indicated by flanking residue
positions. Protein sequences are shown by name or by Uniprot identifier. Secondary structure annotation (in blue) is derived from the zebrafish OXR2-TLDc
domain (17). -Helices (H) and -strands (S) are indicated by cylinders and arrows, respectively. Species abbreviations: 9CHLO, Bathycoccus prasinos; ACYPI,
Acyrthosiphon pisum (pea aphid); AEDAE, Aedes aegypti (yellow fever mosquito); ARATH, Arabidopsis thaliana; ASCSU, Ascaris suum (pig roundworm); ASHGO,
Ashbya gossypii; CAEEL, C. elegans; CALMI, Callorhinchus milii (ghost shark); CHLRE, Chlamydomonas reinhardtii; CHLVA, Chlorella variabilis; CIOIN, Ciona intesti-
nalis; DANRE, Danio rerio (zebrafish); DAPPU, Daphnia pulex (water flea); DROME, Drosophila melanogaster (fruit fly); HUMAN, Homo sapiens; MONBE, Monosiga
brevicollis (choanoflagellate); MONDO, Monodelphis domestica (opossum); MOUSE, Mus musculus; NASVI, Nasonia vitripennis (wasp); NECAM, Necator americanus
(human hookworm); NEMVE, Nematostella vectensis (starlet sea anemone); SCHPO, S. pombe; SOLLC, Solanum lycopersicum (tomato); SOYBN, Glycine max
(soybean); TRIAD, Trichoplax adhaerens; YARLI, Yarrowia lipolytica; YEAST, Saccharomyces cerevisiae.
FIGURE 4. The TLDc domain reduces levels of oxidative stress in neurons. A, N2a cells were transfected with HA-tagged Ncoa7-B wild-type or mutant
followed by HA staining to visualize Ncoa7-B localization. All mutants were expressed, and their localization was similar to the cytoplasmic localization of
Ncoa7-B wild type. Scale bar: 100 m. B, cell death was quantified by counting the number of pyknotic nuclei of N2a cells transfected with wild-type or mutant
Ncoa7-B under oxidative stress and treated with 150 M arsenite for 4 h. Cell death was compared with levels in cells transfected with control vector (*, p  0.05;
**, p  0.01; ***, p  0.001) or with Ncoa7-B WT (#, p  0.05; ##, p  0.01). Data are represented as the mean  S.E. using one-way ANOVA with Dunnett’s
multiple comparison test. C, the NCOA7-B mutants were mapped onto the zebrafish OXR2-TLDc domain structure (PDB ID 4ACJ) (17) with mutated residues
labeled in red, side chains as sticks, and glycines as balls. The ribbon color indicates amino acid evolutionary conservation: red (highly conserved), purple (mildly
conserved), and light yellow (low conservation).
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region of the TLDc domain (Fig. 4C). Because this particular
position seemed likely to influence an important structural fea-
ture of the TLDc domain, we extended the alanine scanning to
examine the same glutamic acid in Oxr1 using the oxidative
stress assay; in both Oxr1-FL (E773A) and Oxr1-C (E293A).
The Oxr1-C mutation led to an approximate 2-fold increase in
the proportion of cell death compared with wild-type Oxr1-C,
suggesting that altering this amino acid was functionally dis-
ruptive, as observed for Ncoa7-B. What was more striking,
however, was the same mutation in Oxr1-FL almost completely
abolished the protective activity of the protein (Fig. 5A), further
illustrating how the context of the TLDc domain within a larger
protein structure may impart different functional properties.
Finally, we assessed mutations in the TLDc domain relevant
to epilepsy by testing a Tbc1d24 A515V mutant (equivalent to
human A509V) (21) as well as a truncation mutant (Cys156X)
to mirror a TBC1D24 frameshift mutation that results in the
loss of the TLDc domain (22). Oxidative stress response assays
demonstrated that the A515V mutation caused a small but
non-significant reduction in cell death compared with a control
vector, suggesting that disrupting the disease-associated ala-
nine residue may not have a major influence on the neuropro-
tective properties of TBC1D24 (Fig. 5B). However, the level of
neuroprotection provided by the C156X mutant was as low as
that of the control vector or the Oxr1-FL E773A construct (Fig.
5B), suggesting that mutating the highly conserved C-terminal
glutamic acid can be as detrimental to the neuroprotective
properties of a TLDc protein as losing the entire TLDc domain.
To relate these findings to oxidative stress levels, we went on
to measure ROS levels in N2a cells expressing each of the
mutant constructs (Fig. 5C). These data suggest that there is
some correlation between the levels of ROS and how function-
ally disruptive the mutations were in the cell survival assay (Fig.
5C). For example, expressing the helix-associated mutants
(G93A) did not significantly reduce cell death or ROS, and the
same outcome was observed for the Oxr1-FL E773A mutant
(Fig. 5C). Conversely, the least destabilizing mutation in
Ncoa7-B, G123A, resulted in significantly lower ROS levels,
equivalent to cells expressing wild-type Ncoa7-B (Fig. 5C).
Taken together, these data show that conserved amino acids at
key structural positions in the TLDc domain are required to
maintain its functional properties in oxidative stress resistance.
Lipid peroxidation and protein S-nitrosylation are the two
main consequences of increased cellular ROS, and these pro-
cesses have been implicated in triggering neurodegeneration
(2). Thus, we first assessed whether overexpression of TLDc
proteins would reduce the level of lipid peroxidation in arsen-
ite-treated N2a cells. No differences in peroxidation were
observed between cells transfected with either the empty con-
trol vector or any of the wild-type TLDc constructs (Fig. 5D).
Interestingly, cells overexpressing a mutant version of Oxr1-C
(E293A) shown to be functionally disruptive (Fig. 5A) caused a
significant increase in peroxidation compared with those trans-
fected with the wild-type Oxr1-C vector (Fig. 5D). None of the
other mutants affected the global levels of lipid peroxidation in
transfected cells however.
We also quantified the level of protein S-nitrosylation under
the same oxidative stress conditions. Protein S-nitrosylation
levels were significantly decreased in cells overexpressing wild-
type Ncoa7-B but not those transfected with Oxr1-C, Oxr1-FL,
or Tbc1d24 (Fig. 6A). Importantly, mutations in Ncoa7-B that
we have demonstrated are essential for the neuroprotective
FIGURE 5. Specific residues in the TLDc domain are necessary to confer
neuroprotection. A–D, N2a cells were transfected with either wild-type or
mutant Oxr1, Ncoa7, or Tbc1d24 as indicated and treated with 150 M arsen-
ite for 4 h (A and B) or 50 M arsenite for 5 h (C) or 4 h (D). A and B, cell death was
assessed by counting the number of pyknotic nuclei compared with cells
transfected with the control empty vector (***, p  0.001; *, p  0.05) or the
corresponding wild-type construct (##, p  0.01; #, p  0.05). C, the level of
cellular oxidative stress was quantified using the fluorescent dihydro-
ethidium and compared with the level of fluorescence in cells transfected
with empty control vector. D, the level of lipid peroxidation (malondialde-
hyde (MDA)) was quantified using fluorescein fluorescence compared with
cells transfected with the corresponding empty (*, p  0.05; **, p  0.01; ***,
p  0.00) or the wild-type vector (#, p  0.05; ##, p  0.01). Data are repre-
sented as the mean  S.E. using one-way ANOVA with Dunnett’s multiple
comparison test or t test).
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properties of the protein (for example, G93A and E216A; Fig.
4B) significantly increased the level of protein S-nitrosylation
compared with cells transfected with wild-type Ncoa7-B (Fig. 6,
A and B). Furthermore, cells overexpressing mutants of other
TLDc proteins (Oxr1-FL E773A, Oxr1-C E293A, and Tbc1d24
A515V) showed significantly higher levels of protein S-nitrosy-
lation than those transfected with the corresponding wild-type
protein (Fig. 6A). These data suggest that TLDc proteins can
modulate protein S-nitrosylation levels to protect neurons
against oxidative stress.
Disruption of the TLDc Domain in Oxr1 Causes Neurodegen-
eration in Vivo—We showed previously that a mouse deletion
mutant (bella) lacking all isoforms of Oxr1 and of the neighbor-
ing gene Abra displays ataxia from postnatal day (P) 20 and
progressive apoptotic cell death in the cerebellar granule cell
layer before death at approximately P26 (8). However, we
wanted to specifically examine the disruption of the TLDc
domain in the context of an in vivo mammalian system. There-
fore, a new mouse mutant was generated in which the TLDc
domain-coding exons shared by both Oxr1-FL and Oxr1-C
were mutated by insertion of a LacZ reporter downstream of a
splice acceptor site (Fig. 7A) (39). In this model any Oxr1 iso-
forms containing the TLDc domain will be truncated, losing the
final 101 C-terminal amino acids. Homozygous mice carrying
two copies of the mutant Oxr1 allele (Oxr1tm1a/tm1a) were gen-
erated from heterozygous animals, and -galactosidase stain-
ing of the brain at P18 (Fig. 7B) demonstrated an expression
pattern almost identical to the Oxr1 in situ hybridization profile
(Fig. 1C), as expected. In addition, we confirmed that expres-
sion of Oxr1-FL and Oxr1-C transcripts upstream of the inser-
tion were present in the brain of Oxr1tm1a/tm1a animals (data
not shown). Importantly, Oxr1tm1a/tm1a mutants displayed pro-
gressive cerebellar degeneration and ataxia to the same degree
as the original homozygous Oxr1 deletion mutants and over an
identical timescale (Fig. 7, C and D). These data confirm that
the TLDc domain is essential for Oxr1 function in vivo.
Discussion
Here we present the first systematic functional investigation
of the TLDc family of proteins performed in parallel. We dem-
onstrate that each protein has the ability to protect neuronal
cells from oxidative stress and that conserved residues and sec-
ondary structures within the TLDc domain are required for
these important functional properties.
Since the original description of OXR1, it has been hypothe-
sized that this protein plays an important role in oxidative stress
resistance (7, 9). Evidence has since been accumulating that this
protein is involved in a number of key stress response pathways
that can be influenced by manipulating its expression (8, 10, 11,
13, 15, 43). Indeed, the importance of OXR1 and related TLDc
domain-containing genes has been emphasized by the discov-
ery that their disruption or deletion can result in a reduced
lifespan in Caenorhabditis elegans (13), Anopheles gambiae
(11), Drosophila (30), and mice (8) or cause a range of inherited
human neurological disorders (20 –22, 26, 44 – 46). Conversely,
overexpression of TLDc proteins has been shown to increase
life expectancy both in normal and disease-associated systems,
for example in Drosophila (43) and mouse (14). Therefore, we
focused this study on the TLDc domain as the significance of
this highly conserved region has not been studied in a compar-
ative manner to date.
We provide the first systematic expression data of TLDc
domain-containing genes in embryonic and adult tissues,
including Kiaa1609 and C20Orf118, which have not been stud-
ied previously in mammalian systems. These data emphasized
that each gene displays a distinct expression profile, although
there are tissues and cell types where their expression is likely to
overlap. It is also noteworthy that both the shortest TLDc
domain-containing isoforms of Oxr1 and Ncoa7 are differen-
tially expressed in certain tissues compared with the corre-
sponding full-length genes; this is likely to be a reflection of
their distinct promoters and potentially different functional
requirements. For example, a shift in the splicing profile of
human NCOA7, favoring NCOA7-AS (Ncoa7-B in mouse) over
NCOA7-FL, is observed in macrophages stimulated with
lipopolysaccharide, which models an immune insult (47). In
addition, NCOA7-AS specifically is induced in interferon--
treated peripheral blood mononuclear cells from healthy par-
ticipants or patients with the autoimmune disease multiple
sclerosis (41). There are several examples where independently
regulated isoforms of a gene are functionally distinct, for
instance only one particular variant of insulin-like growth fac-
tor 1 (Igf1) is beneficial in an in vivo model of ALS (48, 49) or is
FIGURE 6. The TLDc domain is required to reduce levels of S-nitrosylated
proteins in neurons. A and B, N2a cells were transfected with either wild-
type or mutant TLDc constructs as indicated and treated with 50 M arsenite
for 4 h. A, the cellular levels of S-nitrosylated proteins were quantified and
compared with signal intensity in cells transfected with empty vector (*, p 
0.05; **, p  0.01; ***, p  0.001) or the corresponding wild-type construct
(###, p  0.001). Data are represented as the mean  S.E. using one-way
ANOVA with Dunnett’s multiple comparison test or t test, respectively. B,
representative images of cells stained for S-nitrosylated proteins after trans-
fection with the Ncoa7-B constructs indicated and treated with arsenite. Scale
bar: 100 m.
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able to protect cardiomyocytes from oxidative stress insults
(50). Indeed, we have shown previously that Oxr1-C has protein
binding partners distinct from Oxr1-FL (15), further emphasiz-
ing the importance of studying independently the various TLDc
domain-containing isoforms of this protein family.
As deletion of Oxr1 causes decreased oxidative stress resis-
tance in neuronal cells (8), we tested whether the same effect
would be observed for Ncoa7, Tbc1d24, and Kiaa1609 and
found that a 54 – 64% knockdown of these three genes did not
significantly increase sensitivity to oxidative stress. However,
we demonstrated that an 82% knockdown of Oxr1 is sufficient
to render cells more susceptible to oxidative stress-induced
degeneration. This is consistent with previous studies in corti-
cal neurons lacking Oxr1 (8). Moreover, we have shown previ-
ously that mice heterozygous for the bella Oxr1 deletion, thus
with only a partial reduction of Oxr1 levels, were phenotypically
normal (8). Taken together, this suggests there is a threshold
level of TLDc gene expression below which other cellular
mechanisms, or even other TLDc proteins, cannot compensate.
Interestingly, the deregulation of the TLDc family has been
demonstrated in several disease states, including an increase in
OXR1 protein expression in end-stage ALS spinal cord biopsies
(8) and a reduction in OXR1 in the posterior cingulate cortex of
patients with Parkinson disease (51). In addition, levels of
NCOA7 are reported to correlate with the clinical outcome
of neuroblastomas (52). Thus, it appears that tight regulation of
the TLDc domain-containing genes is a key feature of their
neuroprotective properties; whether deregulation occurs at
critical pre-symptomatic stages of disease warrants further
investigation.
Our data suggest that the TLDc domain alone is able to con-
fer oxidative resistance properties to all the TLDc members.
This is in part corroborated by the observation that the shortest
isoforms expressed in human and mouse, Oxr1-C and Ncoa7-B,
are also functional in our assays despite containing almost
exclusively the TLDc domain (8). A previous attempt to map
FIGURE 7. The TLDc is necessary for neuronal survival in vivo. A, schematic of mouse Oxr1-FL (based on accession number NM_130885) and Oxr1-C isoforms,
showing the location of the LacZ insertion (for details see “Experimental Procedures”) that disrupts both isoforms of the protein by splicing-in from exon 12
(denoted as the tm1a allele of Oxr1). Note that exon 9 as shown is unique to Oxr1-C. Exons containing the TLDc domain are shown in gray. B, -galactosidase
staining of the brain of a mouse homozygous for the Oxr1 tm1a allele (Oxr1tm1a/tm1a). C, homozygous Oxr1tm1a/tm1a and bella (bel/bel) mice show a very similar
pattern and distribution of TUNEL-positive (red) in the granule cell layer of the cerebellum at P21 compared with Oxr1tm1a/ animals where no cell death was
observed. These data are quantified in D. Data are represented as the mean  S.E. using one-way ANOVA with Dunnett’s multiple comparison test (***, p 
0.001). Scale bars: 1 mm in B and 400 m in C. Higher (2) magnification is shown in the inset panels.
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the region of full-length OXR1 that confers oxidative stress
resistance utilized a spontaneous mutagenesis assay in a DNA
repair-deficient strain of E. coli (16). Human OXR1 deletion
mutants were assessed, revealing that a particular exon of
OXR1 (upstream of the TLDc domain, equivalent to exon 8; Fig.
7) encoded the anti-oxidant function. This apparent discrep-
ancy with our current study could be explained by an organism-
specific mode of action, although this is unlikely as human
OXR1 has been shown to rescue a S. cerevisiae OXR1 mutant
phenotype, suggesting that there is functional conservation
between species (9). The observations may, therefore, be due to
the different methods used to assess oxidative stress resistance
or that the two distinct regions or isoforms of OXR1 act via
independent antioxidant mechanisms (16). For example, it has
been proposed that the TLDc domain-containing proteins can
influence the expression of key oxygen free-radical scavengers
that, in turn, reduce the levels of ROS in the cell. Indeed, there
is evidence that Oxr1 can modulate the expression of catalase
(11), heme oxygenase (10), and glutathione peroxidase (8, 10,
11), potentially via a p21/NRF2-dependent pathway (10). Local-
ization of OXR1 in the nucleus has also been described (53);
however, which regions of the protein could directly or indi-
rectly influence the transcription of these genes is still
unknown.
It has also been hypothesized that the unique first coding
exon of Ncoa7-B (NCOA7-AS in human) contains amino acid
signatures of an aldo/keto reductase-like domain that could be
responsible for the anti-oxidant properties of this short isoform
(41). However, this hypothesis was based on a limited amino
acid sequence alignment, whereas the entire aldo/keto reduc-
tase-like domain is predicted to be 300 amino acids long (54).
Thus, we believe it is unlikely that the 25 amino acids of the
Ncoa7-AS first exon could constitute or confer a functional
enzymatic domain on its own.
Our own structural modeling combined with functional
assays has highlighted for the first time the significance of cer-
tain highly conserved amino acids in the TLDc domain and how
the context of this domain in the entire protein is critical. For
example, mutating a conserved glycine residue (Gly-93 in
Ncoa7-B; Figs. 3 and 4B) between -helices 3 and 4 is highly
detrimental to the oxidative stress resistance function of the
domain (Fig. 3). Examining this position in more detail, the
main chain torsion angles  and  (Ramachandran angles) at
this position are 102o and 179o (55); only a glycine residue is
sufficiently flexible to accommodate these torsion angles, and
therefore, the G93A mutation will likely compromise the cor-
rect placement of -helices 3 and 4 during folding. We also
focused on a C-terminal glutamic acid (Glu-216 in Ncoa7-B;
Figs. 3 and Fig. 4C), as it is not only highly conserved in all TLDc
proteins but it was also predicted to interact with a serine resi-
due (Ser-60) bringing the N-terminal region of the TLDc
domain into close proximity. We predict that the N-terminal
region is the most flexible of the entire domain; therefore, it is
likely that a mutation of this key glutamic acid residue would
reduce the stability of the N-terminal region and displace one of
the -helices (H1, Fig. 4C). Indeed, mutations at this position
were detrimental to the protective properties of the short iso-
forms of both Oxr1 and Ncoa7 but resulted in a surprising,
almost complete loss-of-function in the full-length Oxr1-FL
isoform. This suggests that allosteric interactions between the
TLDc and other accompanying domains in this family of pro-
teins may be significant.
Consistent with this hypothesis, compound heterozygous
mutations in TBC1D24, one in the TBC domain and another in
the TLDc domain, cause familial infantile myoclonic epilepsy
(FIME), whereas the parents carrying either one of these muta-
tions are phenotypically normal (21). Thus the TLDc mutation
in this context must be deleterious as it is unable to compensate
for the other mutant allele in the TBC domain. Previous cellular
studies revealed that this TLDc mutation (A509V) did not
influence the binding of TBC1D24 to ARF6; however, it was
striking that the same epileptogenic TLDc amino acid change
completely reverted the ARF6-dependent neurite outgrowth
phenotype associated with TBC1D24 overexpression (21).
Thus these data support the notion that the TLDc domain is
essential for the normal function of TBC1D24. Moreover, we
have shown here that the TLDc domain of Tbc1d24 can also
elicit protection against oxidative stress and that mutations
truncating Tbc1d24, as described in the most severe neurolog-
ical conditions associated with this gene (22), abolishes this
property.
In this study we focused on the protective properties of the
TLDc family in neuronal cells; however, it has become apparent
that TLDc proteins may also play an important role in infection
and immunity (12, 14, 41, 56). For example, these proteins may
protect against ROS that are generated as part of the normal
immune response to infection (12). Furthermore, the therapeu-
tic use of Oxr1 has also been tested successfully in a model of
diabetic retinopathy (53) and in kidneys of a nephritis mouse
model using Oxr1-overexpressing mesenchymal stem cells
(57). Taken together, these data demonstrate that Oxr1 pos-
sesses an important and evolutionarily conserved protective
function that could be exploited therapeutically in the future. In
summary, our study provides important new functional insight
into a family of proteins that contain the highly conserved
TLDc domain and its vital role in oxidative stress protection
and in a range of human neurological disorders.
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